9.945
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt AVXL?
Forum
Prognose
Aktiensplit
Anavex Life Sciences Corporation Aktie (AVXL) Neueste Nachrichten
Anavex Life Sciences Corp. (NASDAQ:AVXL) Q3 2025 Earnings Call Transcript - MSN
Anavex Life Sciences Amends Executive Employment Contracts - MSN
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... - Yahoo Finance
Anavex Life Sciences Corp (AVXL) Q3 2025 Earnings Call Highlights: Strong Cash Position and ... By GuruFocus - Investing.com Canada
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders - ACCESS Newswire
Anavex Life Sciences: Fiscal Q3 Earnings Snapshot - Greenwich Time
Context Therapeutics Inc. shares fall 1.47% premarket after Anavex Life Sciences reports fiscal 2025 third quarter results. - AInvest
Anavex Life Sciences Reports Q3 2025 Financial Results - TipRanks
Real time social sentiment graph for Anavex Life Sciences Corp.Entry Point & Long-Term Safe Return Strategies - Newser
Can a trend reversal in Anavex Life Sciences Corp. lead to recoveryChart Signals & High Accuracy Swing Trade Signals - Newser
Achieve Life Sciences, Inc. shares rise 2.42% after-hours following positive earnings report. - AInvest
Anavex Life Sciences shares fall 4.76% intraday after reporting a wider fiscal Q3 loss. - AInvest
Earnings call transcript: Anavex Life Sciences Q3 2025 sees R&D drop By Investing.com - Investing.com South Africa
Earnings call transcript: Anavex Life Sciences Q3 2025 sees R&D drop - Investing.com UK
Anavex Life Sciences Reports Fiscal 2025 Third Quarter Financial Results and Provides Business Update - The Globe and Mail
Anavex Life Sciences Corp. Q3 Loss Increases, Misses Estimates - Nasdaq
Anavex Life Sciences Fiscal Q3 Loss Widens - MarketScreener
Anavex Life Sciences Corp. Reports Q3 Fiscal 2025 Financial Results and Webcast Announcement - Quiver Quantitative
Earnings Flash (AVXL) Anavex Life Sciences Posts Fiscal Q3 Net Loss $0.16 a Share, vs. FactSet Est of $0.14 Loss - MarketScreener
Anavex Reports Breakthrough: Oral Alzheimer's Drug Maintains Benefits After 4 Years as Cash Position Tops $100M - Stock Titan
How high can Anavex Life Sciences Corp. stock goRSI and MACD Signal Summary with Trends - Newser
Understanding Anavex Life Sciences Corp.’s price movementSmart Trade Mapping with Entry Details - Newser
Why Anavex Life Sciences Corp. stock attracts strong analyst attentionSwing Watchlist With Tight Stop Placement - Newser
Sector ETF performance correlation with Anavex Life Sciences Corp.Stock Entry Points Based on Technicals - Newser
Historical volatility pattern of Anavex Life Sciences Corp. visualizedEquity Portfolio Outlook and Performance Summary - Newser
What technical models suggest about Anavex Life Sciences Corp.’s comebackPrice Movement and Market Sentiment Analysis - Newser
Published on: 2025-08-10 02:07:10 - Newser
Can Anavex Life Sciences Corp. recover in the next quarterROI Focused Setup Screener With Exit Markers - Newser
How Resilient Is Anavex Life Sciences Corp. Stock During Economic DownturnsFree Risk Controlled Short Term Trade Plans - Newser
Is Anavex Life Sciences Corp. stock reversal real or fakeIntraday Price Forecast Using Volume Models - Newser
Will Anavex Life Sciences Corp. outperform the marketVolume Spike Detection for Early Breakouts - Newser
Risk adjusted return profile for Anavex Life Sciences Corp. analyzedChart Signal and Short-Term Forecast Tracker - Newser
Envestnet Asset Management Inc. Sells 6,064 Shares of Anavex Life Sciences Corp. (NASDAQ:AVXL) - Defense World
D. Boral Capital Reiterates Buy Rating for Anavex Life Sciences (NASDAQ:AVXL) - Defense World
Identifying reversal signals in Anavex Life Sciences Corp.Trend Following Ideas with Volume Confirmation - Newser
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Finan - GuruFocus
Anavex Life Sciences Corp. Schedules Third Quarter Financial Results and Conference Call for August 12, 2025 - Quiver Quantitative
Anavex Life Sciences Earnings: Latest Updates on Alzheimer's and Parkinson's Drug Development Coming August 12 - Stock Titan
Anavex Life Sciences to Announce Fiscal 2025 Third Quarter Financial Results on Tuesday, August 12, 2025 - The Manila Times
Alzheimer's Disease Disease-Modifying Therapies Markets, 2023-2025 & 2026-2030 | Key Marketed Products, Clinical Trials, Competitive Scenario and R&D Activities - GlobeNewswire Inc.
What data driven models say about Anavex Life Sciences Corp.’s futureFree Stock Market Watch With Alerts - Newser
Can Anavex Life Sciences Corp. rally from current levelsHigh Confidence Strategy with Trend Alignment - Newser
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):